REAL-WORLD DATA
CLINICAL EXPERTISE
DIGITAL SOLUTIONS

Creating the standard for behavioral health

with best-in-class real-world evidence

Innovation in behavioral health has long been hindered by a lack of standardization, including few universal measurements, a reliance on subjectivity, and limited evidence.

At Holmusk we build real-world data and analytics solutions to create a single source of truth for behavioral health. Our solutions help our partners generate evidence to enable successful treatment development, enhanced care delivery, and improved patient outcomes.

We’re ready to set the standard for behavioral health.

GET STARTED

WHAT WE DO

Curating clinical data for deeper insights

We curate real-world data to enable better evidence—because we can’t improve patient outcomes until we first understand how care is actually delivered.

For clinical research

Gain actionable insights from a powerful evidence engine fueled by the behavioral health field’s most robust clinical database containing de-identified electronic health records from patients across the U.S.

LEARN MORE

For clinical care

Enhance care management with a clinical insights solution that visualizes electronic health record data and identifies high-risk cases—ensuring patients get the right care at the right time.

LEARN MORE

OUR WORK IN ACTION

Producing elevated evidence and powerful publications

Otsuka Pharmaceutical
Co., Ltd.

A peer-reviewed manuscript in Current Medical Research and Opinion uses NeuroBlu to healthcare utilization rates for patients with schizophrenia and bipolar disorder.

Read More

Cytel

Catch up on the latest company announcements, including news about novel collaborations, innovative projects, awards, and more.

Read More

JPS Health Network

Curious about the latest developments in real-world evidence and mental health? Check out our blog, the Hol Picture, where leaders from across Holmusk share thoughts.

Read More

LEARN MORE

Behavioral Health Conditions, including

Behavioral Health Assessments

Pharmacological Treatments

Contact Us

Information on a wide variety of conditions, such as:

•Substance use disorders: 255k+ patients

•Major depressive disorder: 251k+ patients

•Bipolar disorder: 134k+ patients

•Attention-deficit/hyperactivity disorder: 82k+ patients

•Post-traumatic stress disorder: 63k+ patients

•Schizoaffective disorder: 34k+ patients

•Schizophrenia: 33k+ patients

•Borderline personality disorder: 19k+ patients

•Autism spectrum disorder: 16k+ patients

Access to behavioral health assessments, enabling researchers to study disease severity and outcomes. These assessments include:

•Substance use disorders: 255k+ patients

•Major depressive disorder: 251k+ patients

•Bipolar disorder: 134k+ patients

•Attention-deficit/hyperactivity disorder: 82k+ patients

•Post-traumatic stress disorder: 63k+ patients

•Schizoaffective disorder: 34k+ patients

•Schizophrenia: 33k+ patients

•Borderline personality disorder: 19k+ patients

•Autism spectrum disorder: 16k+ patients

Access to rich data on pharmacological treatments, giving researchers the ability to determine effectiveness of treatments for patient subsegments, and identify trends to inform precision psychiatry. These treatments include:

•Substance use disorders: 255k+ patients

•Major depressive disorder: 251k+ patients

•Bipolar disorder: 134k+ patients

•Attention-deficit/hyperactivity disorder: 82k+ patients

•Post-traumatic stress disorder: 63k+ patients

•Schizoaffective disorder: 34k+ patients

•Schizophrenia: 33k+ patients

•Borderline personality disorder: 19k+ patients

•Autism spectrum disorder: 16k+ patients

Holmusk has been recognized for innovation in behavioral health by:

EXPLORE ALL PUBLICATIONS

LEARN MORE

Behavioral Health Conditions, including

Behavioral Health Assessments

Pharmacological Treatments

Contact Us

Information on a wide variety of conditions, such as:

•Substance use disorders: 255k+ patients

•Major depressive disorder: 251k+ patients

•Bipolar disorder: 134k+ patients

•Attention-deficit/hyperactivity disorder: 82k+ patients

•Post-traumatic stress disorder: 63k+ patients

•Schizoaffective disorder: 34k+ patients

•Schizophrenia: 33k+ patients

•Borderline personality disorder: 19k+ patients

•Autism spectrum disorder: 16k+ patients

Access to behavioral health assessments, enabling researchers to study disease severity and outcomes. These assessments include:

•Substance use disorders: 255k+ patients

•Major depressive disorder: 251k+ patients

•Bipolar disorder: 134k+ patients

•Attention-deficit/hyperactivity disorder: 82k+ patients

•Post-traumatic stress disorder: 63k+ patients

•Schizoaffective disorder: 34k+ patients

•Schizophrenia: 33k+ patients

•Borderline personality disorder: 19k+ patients

•Autism spectrum disorder: 16k+ patients

Access to rich data on pharmacological treatments, giving researchers the ability to determine effectiveness of treatments for patient subsegments, and identify trends to inform precision psychiatry. These treatments include:

•Substance use disorders: 255k+ patients

•Major depressive disorder: 251k+ patients

•Bipolar disorder: 134k+ patients

•Attention-deficit/hyperactivity disorder: 82k+ patients

•Post-traumatic stress disorder: 63k+ patients

•Schizoaffective disorder: 34k+ patients

•Schizophrenia: 33k+ patients

•Borderline personality disorder: 19k+ patients

•Autism spectrum disorder: 16k+ patients

Back to top
Contact us
OUR PARTNERS

Real-World Evidence for

Real-World impact

Enabling insights for maximum impact

Our real-world data solutions are leveraged by a wide range of stakeholders who share our vision that better evidence can transform research and care for behavioral health.

R&D for drug development

Medical affairs

Market access and health economics & outcomes research

Payers and value-based care

EXPLORE

1,500,000+

patients

30+

geographically-diverse health systems

20+

years of longitudinal data

check icon

Longitudinal

Follow patients over time with over 20 years of data, spanning inpatient and outpatient sites, including hospitals, emergency rooms, and community psychiatry clinics.

check icon

Fit-for-purpose

Conduct observational studies with data that are curated and ready to address your most challenging research questions.

check icon

Comprehensive

Track patient functioning and outcomes and compare different groups of patients with standardized quantitative outcome measures.

Behavioral health conditions

  • Substance use disorders

538K+ patients

  • Major depressive disorder

387K+ patients

  • Bipolar disorder

216K+ patients

  • Attention-deficit/hyperactivity disorder

122K+ patients

  • Adjustment disorders

108K+ patients

  • Post-traumatic stress disorder

93K+ patients

  • Generalized anxiety disorder

84K+ patients

  • Schizophrenia

76K+ patients

  • Personality disorders

73K+ patients

  • Panic disorder

28K+ patients

      Behavioral health assessments

      • The NeuroBlu Database provides both composite scores for the below measures and responses for individual items within the scoring tools, enabling more granular research.
      • Brief Bipolar Disorder Symptom Scale (BDSS)
      • Brief Negative Symptom Assessment (BNSA)
      • Clinical Global Impressions (CGI-I/CGI-S)
      • Columbia-Suicide Severity Rating Scale (C-SSRS)
      • Global Assessment of Functioning (GAF)
      • Patient Health Questionnaire-9 (PHQ-9)
      • Positive Symptom Rating Scale (PSRS)
      • The Daily Living Activities–20 (DLA-20)
      • The Quick Inventory of Depressive Symptomatology (QIDS)

      Pharmacological treatments

      • The NeuroBlu Database contains information on both psychotherapy and pharmacologic treatments. These include:
      • Antidepressants
      • Antipsychotics
      • Anxiolytics
      • Hypnotics and sedatives
      • Mood stabilizers
      • Psycholeptics
      • Psychostimulants

      Enriched data for deeper clinical context

      The NeuroBlu Database is enriched through the application of natural language processing models—the first to be developed specifically for behavioral health.

      These models extract important information from unstructured clinical notes within the electronic health record and transform it into standardized measures, adding valuable context to research by making more fit-for-purpose data available than ever before.

      Symptoms

      Gain a comprehensive picture of patients' emotions, cognition, and behaviors with data on symptoms that are often not captured in the electronic health record, such as anhedonia for patients with major depressive disorder.

      External stressors

      Explore how life events and psychosocial environmental stressors impact patient outcomes and influence treatment response.

      Social determinants of health

      Better understand how social, relational, and occupational factors may impact behavioral health.

      Holmusk has been recognized for innovation in behavioral health by:

      See How We Collaborate

      Stay Up to Date

      We’d love for you to come along on the journey of improving behavioral health with better evidence.

      Holmusk is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:

      In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.

      Thank you! We will get back to you soon.
      Oops! Something went wrong while submitting the form.

      Singapore

      New York

      London

      Basel

      Berlin

      Terms & Conditions
      Our Work in Action

      Read More Publications

      Conference Abstract

      Instability of Depressive Symptoms Predicts the Onset of Severe Depression Among Patients with Mild-to-Moderate Illness

      May 17, 2025

      Conference Abstract

      Temporal and Contextual Detection of Five Depressive Disorder Symptoms from Unstructured Electronic Health Record Notes Using a Trained Natural Language Processing Model

      May 17, 2025

      Peer-reviewed paper

      Identifying the diagnostic gap of tardive dyskinesia: An analysis of semi-structured electronic health record data

      April 21, 2025

      INNOVATION & INSIGHTS

      Read More

      Curious about what’s happening in the real-world evidence space? Check out our blog, the Hol Picture, where we share takeaways from recent talks and weigh in on news involving real-world evidence and behavioral health.

      Publications

      Explore recent peer-reviewed publications and conference abstracts that leveraged NeuroBlu data to share new real-world evidence with the scientific community.

      Read More

      News

      Catch up on the latest company announcements, including news about novel collaborations, innovative projects, awards, and more.

      Read More

      Thought Leadership

      Curious about the latest developments in real-world evidence and mental health? Check out our blog, the Hol Picture, where leaders from across Holmusk share thoughts.

      Read More

      Stay Up-to-Date

      We’re making fast strides toward a reimagined future for behavioral health, and we’d love for you to come along on our journey.

      Holmusk is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:

      In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.

      Thank you! We will get back to you soon.
      Oops! Something went wrong while submitting the form.